Overview

Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?

Status:
Completed
Trial end date:
2021-06-16
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine whether inducing labor with just one dose of misoprostol, followed by treatment with oxytocin, will still be effective enough to increase the chances of having a successful vaginal delivery as compared to using more than one dose of misoprostol, followed by treatment with oxytocin.
Phase:
Phase 2
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Methotrexate
Misoprostol